Shanghai Bima Life Sciences
PrivateLast Round
Series B
Jan 4, 2022
Est. Valuation
$30.8M
Total Funding Raised
$50M
Company Overview
Shanghai Bima Life Sciences is a biotechnology company that provides a proteomics detection platform based on antibody affinity assay.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Bima Life Sciences Comparables
Compare Shanghai Bima Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriApex Laboratories | 81% | |
| Prisys Biotechnology Co., Ltd. | 81% | |
| Shanghai Medicilon Inc. | 81% |
Shanghai Bima Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2022 | ||||
| Series A Extension | Aug 7, 2020 | ||||
| Series A | Jan 1, 2019 | ||||
| Angel | Jun 1, 2017 |
Shanghai Bima Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series B |
| Sincere Capital | Series B |
| Highlight Capital | Series B |
| Kaitai Capital | Series A Extension, Series A |
| J-One Capital Invest | Series A Extension |
| Shengshan Asset Management | Series A |
| Viva Biotech | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2022
$30M round led by Highlight Capital and Photon Fund.
- Jun 1, 2017
Completed an Angel round of funding.
Shanghai Bima Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Bima Life Sciences's valuation, stock price, and market status.
Is Shanghai Bima Life Sciences a public or private company?
Shanghai Bima Life Sciences is a private company.
What is the current stock price of Shanghai Bima Life Sciences?
Shanghai Bima Life Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai Bima Life Sciences worth (valuation)?
Shanghai Bima Life Sciences's valuation is estimated at $30.8M based on funding round data.
Can I buy Shanghai Bima Life Sciences stock?
Shanghai Bima Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Bima Life Sciences's last funding round?
Shanghai Bima Life Sciences's most recent funding round was Series B on January 1, 2019.
Who are the main investors in Shanghai Bima Life Sciences?
Key investors in Shanghai Bima Life Sciences include Photon Fund, Highlight Capital, Kaitai Capital, 华创资本.
Will Shanghai Bima Life Sciences IPO soon?
No public IPO plans have been announced for Shanghai Bima Life Sciences.
How can I track Shanghai Bima Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Bima Life Sciences's secondary market activity and sign up for updates.